↓ Skip to main content

3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders

Overview of attention for article published in Journal of Biomedical Science, August 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#48 of 1,101)
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
11 X users
patent
2 patents
facebook
2 Facebook pages
wikipedia
6 Wikipedia pages
video
1 YouTube creator

Citations

dimensions_citation
131 Dimensions

Readers on

mendeley
567 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders
Published in
Journal of Biomedical Science, August 2017
DOI 10.1186/s12929-017-0362-8
Pubmed ID
Authors

Chun-Ting Lee, Raphael M. Bendriem, Wells W. Wu, Rong-Fong Shen

Abstract

Three-dimensional (3D) brain organoids derived from human pluripotent stem cells (hPSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), appear to recapitulate the brain's 3D cytoarchitectural arrangement and provide new opportunities to explore disease pathogenesis in the human brain. Human iPSC (hiPSC) reprogramming methods, combined with 3D brain organoid tools, may allow patient-derived organoids to serve as a preclinical platform to bridge the translational gap between animal models and human clinical trials. Studies using patient-derived brain organoids have already revealed novel insights into molecular and genetic mechanisms of certain complex human neurological disorders such as microcephaly, autism, and Alzheimer's disease. Furthermore, the combination of hiPSC technology and small-molecule high-throughput screening (HTS) facilitates the development of novel pharmacotherapeutic strategies, while transcriptome sequencing enables the transcriptional profiling of patient-derived brain organoids. Finally, the addition of CRISPR/Cas9 genome editing provides incredible potential for personalized cell replacement therapy with genetically corrected hiPSCs. This review describes the history and current state of 3D brain organoid differentiation strategies, a survey of applications of organoids towards studies of neurodevelopmental and neurodegenerative disorders, and the challenges associated with their use as in vitro models of neurological disorders.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 567 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 567 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 91 16%
Student > Master 89 16%
Student > Bachelor 77 14%
Researcher 54 10%
Student > Doctoral Student 31 5%
Other 67 12%
Unknown 158 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 103 18%
Neuroscience 87 15%
Agricultural and Biological Sciences 55 10%
Medicine and Dentistry 35 6%
Engineering 31 5%
Other 81 14%
Unknown 175 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2023.
All research outputs
#1,170,375
of 25,382,440 outputs
Outputs from Journal of Biomedical Science
#48
of 1,101 outputs
Outputs of similar age
#23,532
of 325,841 outputs
Outputs of similar age from Journal of Biomedical Science
#1
of 26 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,101 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,841 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.